Intradermal hpv peptide vaccination

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 39/12 (2006.01) C07K 14/025 (2006.01)

Patent

CA 2688589

The invention relates to the use of a peptide derived from HPV-E2, -E6 and/or E7 protein for the manufacture of a medicament for the treatment or prevention of an HPV related disease, wherein the medicament is for intradermal administration.

L'invention concerne l'utilisation d'un peptide dérivé d'une protéine de PVH-E2, -E6 et/ou E7 pour la fabrication d'un médicament utilisé dans le traitement ou la prévention d'une maladie associée au PVH, ce médicament étant administré par voie intradermique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intradermal hpv peptide vaccination does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intradermal hpv peptide vaccination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intradermal hpv peptide vaccination will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1538512

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.